503rd Edition, April 12, 2022

Trouble Viewing This Email: Click Here

April 12, 2022

FOUNDING MEMBER OF

BHI has an immediate opening for a Life Sciences Business Strategist.

Life Sciences Business Strategist

BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). We are seeking a Life Sciences Business Strategist to join our team remotely.

The right candidate will be an energetic and continuous learner who is passionate about accelerating the adoption of new technologies to improve lives. The position is geared toward an early-career scientist (generally in their first 5-7 years after receiving their PhD) who wants to engage with the biohealth industry in new ways.

How can your BioHealth business benefit from a review by BHI industry experts? Please register for our next Entrepreneur-In-Residence (EIR) day on April 20th and find out. (Only 3 spots left!)

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.

To sign-up for any of the EIR dates in 2022, please follow this link.

BiOneCure Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for BIO-106, a Novel TROP2 ADC for the Treatment of Advanced Solid Tumors · BioBuzz

GERMANTOWN, Md., April 6, 2022 /PRNewswire/ — BiOneCure Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the IND for BIO-106, an antibody-drug conjugate (ADC) designed to target TROP-2 to treat a broad range of advanced solid tumors.

The clinical study cleared by the FDA, known as StarBridge-1, is a Phase I/II, multicenter, open-label study to evaluate the safety, pharmacokinetics and preliminary anti-tumor activity of BIO-106 as monotherapy and in combination with pembrolizumab in patients with advanced cancers.

Rockville Economic Development Inc. (REDI) enters strategic partnership with Federal Laboratory Consortium (FLC) – Rockville Economic Development, Inc

WASHINGTON, DC and ROCKVILLE, Md., March 28, 2022 – The Federal Laboratory Consortium (FLC) has entered into a strategic partnership with Rockville Economic Development, Inc. (REDI), based in Rockville, MD as part of an ongoing campaign to help local businesses and entrepreneurs with innovative technologies succeed through collaborations with federal laboratories.

The Rockville Economic Development, Inc. (REDI) was formed in 1997 as a public-private partnership (formerly known as the Greater Rockville Partnership) by the City of Rockville, Maryland, to build the city’s economic base through entrepreneurship, expansion, retention, and recruitment programs. REDI and the FLC signed a Memorandum of Understanding on March 22, 2022.

Senate Confirms Laurie Locascio to Lead Tech Standards Agency – Nextgov

The U.S. Senate confirmed Laurie Locascio, a former bioengineering professor at the University of Maryland, to helm the National Institute of Standards and Technology on Thursday.

Following Locascio’s nomination by President Joe Biden back in 2021, the Senate voted in her favor during an April 8 voice vote. Her nomination was first approved by the Senate Committee on Commerce, Science and Transportation before being sent to the floor for a final vote.

Image: J. STOUGHTON/NIST

What's around the bend for the Maryland tech economy? These local leaders shared some thoughts – Technical.ly

The impacts of various ongoing developments, from the metaverse’s increasing prominence to the forthcoming gubernatorial shift, on Maryland’s tech economy were on the minds of attendees and panelists alike at last Thursday’s Digital Transformation Summit.

The Maryland Tech Council hosted its third iteration of the annual convention, in which the economic development group looks at the Maryland tech economy’s future, at the Maryland Jockey Club in Laurel.

Image: (L to R) Fearless' design director Jordan Watts; Exelon's principal product designer Chris-Anne Correa; Mindgrub's research and experience design director Shannon Hosmer; Christine Jackson, director of digital Strategy for the National Aquarium; and Solomon Scott, engineering lead, for The Washington Post, speak on a panel during the third annual Digital Transformation Summit. – https://technical.ly

What It Means for a Pandemic Like Covid to Become 'Endemic’ – The New York Times

For months, some American and European leaders have foretold that the coronavirus pandemic would soon become endemic. Covid-19 would resolve into a disease that we learn to live with. According to several governors, it nearly has.

But we are still in the acute phase of the pandemic, and what endemic Covid might look like remains a mystery. Endemic diseases can take many forms, and we do not know yet where this two-year-old disease will fall among them.

Image: https://www.nytimes.com

The 'Top 25 Innovators' in health care, according to Modern Healthcare

Modern Healthcare last week released its annual list of the "Top 25 Innovators," recognizing leaders who initiate and lead change in the health care industry.

Methodology For the list, Modern Healthcare accepted nominations from Nov. 22, 2021 to Jan. 31, 2022.

To be eligible, nominees had to be at the director level or higher within a provider organization—including a hospital, health system, clinic, or physician group—or an insurer.

Brian Coblitz Appointed Executive Director of GW Technology Commercialization Office | GW Today | The George Washington University

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AmerisourceBergen, a global healthcare solutions company, today announced the establishment of AB Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with emerging healthcare startup companies working to transform healthcare for people and animals globally. AB Health Ventures will build on AmerisourceBergen’s ongoing commitment to delivering innovation for its customers.

About BioHealth Innovation

Contact

Connect